Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Matthias Bossard Added: 1 week ago
TCT 2025 - The randomized VICTORY Study finds OCT-guided PCI involving lesion preparation with the OPN super-high-pressure non-compliant balloon is non-inferior to intravascular lithotropsy.Dr Matthias Bossard (Kantonsspital Lucerne, Lucerne, CH) joins us to discuss findings from the VICTORY Trial, a randomized, multicenter, non-inferiority comparison evaluating intravascular lithotripsy versus… View more
Author(s): Suzanne J Baron Added: 1 week ago
TCT 2025 — Dr Suzanne J Baron (Massachusetts General Hospital, US), principal investigator of the Short-CUT trial (NCT06089135; Baim Institute for Clinical Research), joins us to discuss this investigator-initiated, multicentre randomized controlled study.The trial enrolled 410 patients with moderate to severe coronary artery calcification across up to 22 international sites. Eligible… View more
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 1 year ago
What's hot at EuroPCR 2024?Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen from Erasmus MC's Thoraxcenter for an insightful preview of the late-breaking science data to look out for at the 2024 EuroPCR meeting.What is the potential impact of the new data on practice? What details should we look out for? What is the context of the EuroPCR trials?Trials covered included:00… View more
Job title: Consultant Interventional Cardiologist
Prof Kelvin Lee is Consultant Interventional Cardiologist at the Lincolnshire Heart Centre with a focus on complex coronary intervention. His expertise includes intra-coronary imaging, rotational atherectomy, intravascular lithotripsy and coronary physiology using iFR and FFR. He leads the Cardiovascular Clinical Research Programme and is Cardio-Metabolic Lead and Deputy Clinical Director of… View more
Author(s): Andrew Holden Added: 6 months ago
What are the unique features of the new intravascular lithotripsy (IVL) devices addressing calcified tibial disease?Prof Andrew Holden (Auckland City Hospital, Auckland, NZ) joins us to discuss two new devices addressing calcified tibial disease, the Shockwave E8 catheter and the Shockwave Javelin catheter. Prof Holden then evaluates the safety and efficacy findings from the Disrupt PAD BTK II… View more
Author(s): Daniel Clair Added: 8 months ago
ISET 2025 - Safety and efficacy outcomes of an intravascular lithotripsy (IVL) catheter used for the treatment of moderate to severely calcified lesions show a high ability to deliver the catheter with access to the lesion and very low rates of myocardial infarction and distal embolisation.Dr Daniel Clair (Vanderbilt University Medical Center, TN, US) joins us to discuss the key findings from the… View more
Author(s): Added: 1 year ago
In this interview, Dr Masaru Seguchi (German Heart Centre, DE) explains the aim of the BIOMAG-I OCT analysis, what the findings were and what the data means for the future of cardiology. View more